Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of November 19, 2026, ERNA trades at $1.64 with a market cap of $2.74M and a P/E ratio of -1.24. ERNA moved +0.00% today. Year to date, ERNA is -94.64%; over the trailing twelve months it is -95.62%. Its 52-week range spans $1.56 to $100.46. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $1.64 |
| Market Cap | $2.74M |
| P/E Ratio | -1.24 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $100.46 |
| 52-Week Low | $1.56 |
| Volume | 12.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.08M |
| Gross Margin | 0.00% |
ERNA analyst coverage data. Average price target: $0.00.